- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 487/10 - Spiro-condensed systems
Patent holdings for IPC class C07D 487/10
Total number of patents in this class: 1645
10-year publication summary
|
113
|
89
|
113
|
132
|
172
|
138
|
146
|
180
|
192
|
64
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 5080 |
54 |
| Hoffmann-La Roche Inc. | 3060 |
49 |
| Boehringer Ingelheim International GmbH | 4629 |
46 |
| F. Hoffmann-La Roche AG | 7958 |
43 |
| Novartis AG | 11238 |
33 |
| The Regents of the University of Michigan | 4409 |
30 |
| Enanta Pharmaceuticals, Inc. | 420 |
29 |
| Tenacia Biotechnology (Hong Kong) Co., Limited | 35 |
29 |
| Takeda Pharmaceutical Company Limited | 2961 |
28 |
| Merck Patent GmbH | 5909 |
26 |
| Merck Sharp & Dohme LLC | 3689 |
26 |
| Janssen Pharmaceutica N.V. | 3839 |
25 |
| Amgen Inc. | 3779 |
21 |
| Aptinyx Inc. | 33 |
21 |
| Daiichi Sankyo Company, Limited | 1829 |
21 |
| Araxes Pharma LLC | 91 |
20 |
| AstraZeneca AB | 3042 |
18 |
| Pfizer Inc. | 3322 |
18 |
| Gilead Sciences, Inc. | 1879 |
18 |
| The Regents of the University of California | 18943 |
16 |
| Other owners | 1074 |